NCT01839331View on ClinicalTrials.gov

An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

329

Participants

Timeline

Start Date

March 29, 2013

Primary Completion Date

August 19, 2013

Study Completion Date

October 31, 2013

Conditions
Osteoarthritis of the Knee
Interventions
BIOLOGICAL

4 mL injection of Ampion

4 mL Injection of Ampion

BIOLOGICAL

10 mL Injection of Ampion

10 mL Injection of Ampion

DRUG

4 mL Injection of Placebo

4 mL Injection of Placebo

DRUG

10 mL Injection of Placebo

10 mL Injection of Placebo

Sponsors
All Listed Sponsors
lead

Ampio Pharmaceuticals. Inc.

INDUSTRY

NCT01839331 - An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter